Cognate BioServices completes MBO and attracts funding

Hanover, Maryland-based Cognate BioServices, a contract development and manufacturing organization in the global cellular therapies industry, has raised an undisclosed amount of funding. The investors included Tennenbaum Capital Partners LLC, Medivate Partners and an unnamed sovereign wealth fund. Also, Cognate has completed a management buyout.

DealsNorth AmericaUSHealthcareBriefs